| Price | 418.85 on 29-09-2026 at 16:35:07 |
|---|---|
| Change | -5.60 -1.32% |
| Buy | 427.50 |
| Sell | 410.20 |
| Last Trade: | Sell 376.00 at 418.50 |
| Day's Volume: | 29,638 |
| Last Close: | 418.85 |
| Open: | 423.35 |
| ISIN: | DK0060336014 |
| Day's Range | 414.00 - 423.70 |
| 52wk Range: | 336.00 - 464.15 |
| Market Capitalisation: | - |
| VWAP: | 418.85428 |
| Shares in Issue: | 466.47m |
Novonesis B Ord (0Q4U) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 376 | 418.50 | SI Trade |
15:54:30 - 29-Sep-26 |
| Sell* | 2 | 418.30 | SI Trade |
15:54:00 - 29-Sep-26 |
| Sell* | 97 | 418.10 | SI Trade |
15:53:15 - 29-Sep-26 |
| Sell* | 236 | 417.90 | SI Trade |
15:52:44 - 29-Sep-26 |
| Sell* | 248 | 417.30 | SI Trade |
15:51:25 - 29-Sep-26 |
| Sell* | 1,553 | 417.40 | SI Trade |
15:51:06 - 29-Sep-26 |
| Sell* | 5 | 417.25 | SI Trade |
15:50:18 - 29-Sep-26 |
| Sell* | 4 | 417.25 | SI Trade |
15:50:18 - 29-Sep-26 |
| Sell* | 57 | 417.25 | SI Trade |
15:50:13 - 29-Sep-26 |
| Sell* | 14 | 417.25 | SI Trade |
15:49:49 - 29-Sep-26 |
Novonesis B Ord (0Q4U) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 16th Mar 2026 12:14 pm | RNS-R | Novonesis issues EUR 1.7 billion in bonds to refinance bridge facility |
| 9th Jul 2018 1:13 pm | GNW | Transactions under Novozymes’ stock buyback program |
| 2nd Jul 2018 12:28 pm | GNW | Transactions under Novozymes’ stock buyback program |
| 25th Jun 2018 11:14 am | GNW | Transactions under Novozymes’ stock buyback program |
| 18th Jun 2018 10:06 am | GNW | Transactions under Novozymes’ stock buyback program |
| 11th Jun 2018 11:59 am | GNW | Transactions under Novozymes’ stock buyback program |
| 4th Jun 2018 7:49 am | GNW | Transactions under Novozymes’ stock buyback program |
| 28th May 2018 9:34 am | GNW | Transactions under Novozymes’ stock buyback program |
| 22nd May 2018 12:20 pm | GNW | Transactions under Novozymes’ stock buyback program |
| 14th May 2018 12:21 pm | GNW | Transactions under Novozymes’ stock buyback program |
